EUVIMEDEUVIMED entdecken
BeobachtungsstudieVergleichsstudieOpen Access · CC BY-NC 3.0

Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study

Mathew Cherian, Sophie Dell'Aniello, Samy Suissa iD

International Journal of Chronic Obstructive Pulmonary Disease · 2026-05 · Volume 21 · 1-14

DOI: 10.2147/copd.s585037 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2026-05. Verfasst von Mathew Cherian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Respiratory Division, McGill University, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Benzyl Alcohols, Bronchodilator Agents, Formoterol Fumarate, Lung. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Benzyl AlcoholsBronchodilator AgentsFormoterol FumarateLungPulmonary Disease, Chronic ObstructiveAgedFemaleHumansMaleMiddle AgedAdministration, InhalationAdrenergic beta-2 Receptor AgonistsBeclomethasoneChlorobenzenesDatabases, FactualDisease ProgressionDrug CombinationsGlucocorticoidsGlycopyrrolateMuscarinic AntagonistsPneumoniaQuinuclidinesRisk FactorsTime FactorsTreatment Outcome

Stichwörter der Autor:innen

COPD exacerbationscohort studiesnew-user designobservational studypneumonia

Substanzen

Adrenergic beta-2 Receptor AgonistsBeclomethasoneBenzyl AlcoholsBronchodilator AgentsChlorobenzenesDrug CombinationsFormoterol FumarateGlucocorticoidsGlycopyrrolateGSK573719

Autor:innen und Institutionen

  • Department of Medicine, Respiratory Division, McGill University, Montreal, Quebec, Canada.
  • Centre for Clinical Epidemiology, Lady Davis Institute-Jewish General Hospital, Montreal, Quebec, Canada.
  • Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.

ORCID-Profile: Samy Suissa

Zitieren

APA

Cherian, M., Dell'Aniello, S., & Suissa, S. (2026). Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study. International Journal of Chronic Obstructive Pulmonary Disease, Volume 21, 1-14. https://doi.org/10.2147/copd.s585037

Vancouver

Cherian M, Dell'Aniello S, Suissa S. Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study. International Journal of Chronic Obstructive Pulmonary Disease. 2026;Volume 21:1-14. doi:10.2147/copd.s585037

BibTeX
@article{Cherian2026,
  author = {Cherian, Mathew and Dell'Aniello, Sophie and Suissa, Samy},
  title = {Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2026},
  volume = {Volume 21},
  pages = {1--14},
  doi = {10.2147/copd.s585037}
}
Kostenlos starten →